-
Something wrong with this record ?
Brain metabolism and diffusion in the rat cerebral cortex during pilocarpine-induced status epilepticus
K. Slais, I. Vorisek, N. Zoremba, A. Homola, L. Dmytrenko, E. Sykova
Language English Country United States
- MeSH
- Muscarinic Agonists MeSH
- Diffusion Magnetic Resonance Imaging MeSH
- Potassium metabolism MeSH
- Electroshock MeSH
- Energy Metabolism physiology drug effects physiology MeSH
- Extracellular Space metabolism drug effects MeSH
- Financing, Organized MeSH
- Glucose metabolism MeSH
- Rats MeSH
- Lactic Acid MeSH
- Membrane Potentials physiology MeSH
- Microdialysis MeSH
- Brain Chemistry physiology drug effects MeSH
- Cerebral Cortex metabolism physiopathology MeSH
- Pilocarpine MeSH
- Rats, Wistar MeSH
- Sodium metabolism MeSH
- Status Epilepticus chemically induced metabolism physiopathology MeSH
- Body Water metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
The real-time iontophoretic method using tetramethylammonium-selective microelectrodes and diffusion-weighted magnetic resonance imaging were used to measure the extracellular space volume fraction alpha, tortuosity lambda and apparent diffusion coefficient of water (ADC(W)) 240 min after the administration of pilocarpine in urethane-anaesthetized rats. The obtained data were correlated with extracellular lactate, glucose, and glutamate concentrations and the lactate/pyruvate-ratio, determined by intracerebral microdialysis. The control values of alpha and lambda were 0.19+/-0.004 and 1.58+/-0.01, respectively. Following pilocarpine application, alpha decreased to 0.134+/-0.012 100 min later. Thereafter alpha increased, reaching 0.176+/-0.009 140 min later. No significant changes in lambda were observed during the entire time course of the experiment. ADC(W) was significantly decreased 100 min after pilocarpine application (549+/-8 microm(2) s(-1)) compared to controls (603+/-11 microm(2) s(-1)); by the end of the experiments, ADC(W) had returned to control values. The basal cortical levels of lactate, the lactate/pyruvate ratio, glucose and glutamate were 0.61+/-0.05 mmol/l, 33.16+/-4.26, 2.42+/-0.13 mmol/l and 6.55+/-1.31 micromol/l. Pilocarpine application led to a rise in lactate, the lactate/pyruvate ratio and glutamate levels, reaching 2.92+/-0.60 mmol/l, 84.80+/-11.72 and 22.39+/-5.85 micromol/l within about 100 min, with a subsequent decrease to control values 140 min later. The time course of changes in glucose levels was different, with maximal levels of 3.49+/-0.24 mmol/l reached 40 min after pilocarpine injection and a subsequent decrease to 1.25+/-0.40 mmol/l observed 200 min later. Pathologically increased neuronal activity induced by pilocarpine causes cell swelling followed by a reduction in the ECS volume fraction, which can contribute to the accumulation of toxic metabolites and lead to the start of epileptic discharges.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026197
- 003
- CZ-PrNML
- 005
- 20120917115453.0
- 008
- 101018s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Šlais, Karel $7 xx0071058
- 245 10
- $a Brain metabolism and diffusion in the rat cerebral cortex during pilocarpine-induced status epilepticus / $c K. Slais, I. Vorisek, N. Zoremba, A. Homola, L. Dmytrenko, E. Sykova
- 314 __
- $a Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. kslais@med.muni.cz
- 520 9_
- $a The real-time iontophoretic method using tetramethylammonium-selective microelectrodes and diffusion-weighted magnetic resonance imaging were used to measure the extracellular space volume fraction alpha, tortuosity lambda and apparent diffusion coefficient of water (ADC(W)) 240 min after the administration of pilocarpine in urethane-anaesthetized rats. The obtained data were correlated with extracellular lactate, glucose, and glutamate concentrations and the lactate/pyruvate-ratio, determined by intracerebral microdialysis. The control values of alpha and lambda were 0.19+/-0.004 and 1.58+/-0.01, respectively. Following pilocarpine application, alpha decreased to 0.134+/-0.012 100 min later. Thereafter alpha increased, reaching 0.176+/-0.009 140 min later. No significant changes in lambda were observed during the entire time course of the experiment. ADC(W) was significantly decreased 100 min after pilocarpine application (549+/-8 microm(2) s(-1)) compared to controls (603+/-11 microm(2) s(-1)); by the end of the experiments, ADC(W) had returned to control values. The basal cortical levels of lactate, the lactate/pyruvate ratio, glucose and glutamate were 0.61+/-0.05 mmol/l, 33.16+/-4.26, 2.42+/-0.13 mmol/l and 6.55+/-1.31 micromol/l. Pilocarpine application led to a rise in lactate, the lactate/pyruvate ratio and glutamate levels, reaching 2.92+/-0.60 mmol/l, 84.80+/-11.72 and 22.39+/-5.85 micromol/l within about 100 min, with a subsequent decrease to control values 140 min later. The time course of changes in glucose levels was different, with maximal levels of 3.49+/-0.24 mmol/l reached 40 min after pilocarpine injection and a subsequent decrease to 1.25+/-0.40 mmol/l observed 200 min later. Pathologically increased neuronal activity induced by pilocarpine causes cell swelling followed by a reduction in the ECS volume fraction, which can contribute to the accumulation of toxic metabolites and lead to the start of epileptic discharges.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a tělesná voda $x metabolismus $7 D001834
- 650 _2
- $a mozek - chemie $x fyziologie $x účinky léků $7 D001923
- 650 _2
- $a mozková kůra $x metabolismus $x patofyziologie $7 D002540
- 650 _2
- $a difuzní magnetická rezonance $7 D038524
- 650 _2
- $a elektrický šok $7 D004597
- 650 _2
- $a energetický metabolismus $x fyziologie $x účinky léků $7 D004734
- 650 _2
- $a energetický metabolismus $x fyziologie $7 D004734
- 650 _2
- $a extracelulární prostor $x metabolismus $x účinky léků $7 D005110
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a kyselina mléčná $7 D019344
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové potenciály $x fyziologie $7 D008564
- 650 _2
- $a mikrodialýza $7 D017551
- 650 _2
- $a agonisté muskarinových receptorů $7 D018721
- 650 _2
- $a pilokarpin $7 D010862
- 650 _2
- $a draslík $x metabolismus $7 D011188
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sodík $x metabolismus $7 D012964
- 650 _2
- $a status epilepticus $x chemicky indukované $x metabolismus $x patofyziologie $7 D013226
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Voříšek, Ivan $7 xx0086097
- 700 1_
- $a Zoremba, Norbert
- 700 1_
- $a Homola, Aleš. $7 xx0278724
- 700 1_
- $a Dmytrenko, Leos
- 700 1_
- $a Syková, Eva, $d 1944- $7 jn20000710633
- 773 0_
- $w MED00001749 $t Experimental neurology $g Roč. 209, č. 1 (2008), s. 145-154 $x 0014-4886
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101021142500 $b ABA008
- 991 __
- $a 20120917115633 $b ABA008
- 999 __
- $a ok $b bmc $g 801302 $s 666045
- BAS __
- $a 3
- BMC __
- $a 2008 $b 209 $c 1 $d 145-154 $i 0014-4886 $m Experimental neurology $n Exp Neurol $x MED00001749
- LZP __
- $a 2010-B/jtme